Market Cap 1.27B
Revenue (ttm) 614.38M
Net Income (ttm) -18.52M
EPS (ttm) N/A
PE Ratio 13.82
Forward PE 12.16
Profit Margin -3.01%
Debt to Equity Ratio 0.71
Volume 307,300
Avg Vol 426,030
Day's Range N/A - N/A
Shares Out 21.66M
Stochastic %K 98%
Beta 0.56
Analysts Strong Sell
Price Target $82.62

Latest News on ANIP

ANI Pharmaceuticals: A Short-Term Buying Opportunity

May 6, 2025, 5:43 AM EDT - 4 weeks ago

ANI Pharmaceuticals: A Short-Term Buying Opportunity


ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Mar 19, 2025, 6:50 AM EDT - 2 months ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets


ANI Pharmaceuticals: More Than Just A Generics Company

Feb 11, 2025, 9:08 AM EST - 4 months ago

ANI Pharmaceuticals: More Than Just A Generics Company


Alcami Announces CEO Transition

Jan 13, 2025, 11:12 AM EST - 5 months ago

Alcami Announces CEO Transition


ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

Oct 11, 2024, 4:01 AM EDT - 8 months ago

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market


ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 12:40 PM EDT - 10 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript